Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 12—December 2005
Research

Bartonella henselae in Porpoise Blood

On This Page
Materials and Methods
Results
Discussion
Cite This Article
Downloads
Article
RIS [TXT - 2 KB]
Article Metrics
Metric Details
48
citations of this article
EID Journal Metrics on Scopus
Author affiliations: *North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA; †Center for Marine Sciences and Technology, Morehead City, North Carolina, USA; ‡National Marine Fisheries Service, Beaufort, North Carolina, USA; §University of North Carolina Wilmington, Wilmington, North Carolina, USA; ¶Virginia Aquarium and Marine Science Center, Virginia Beach, Virginia, USA; #University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA

Cite This Article

Abstract

We report detection of Bartonella henselae DNA in blood samples from 2 harbor porpoises (Phocoena phocoena). By using real-time polymerase chain reaction, we directly amplified Bartonella species DNA from blood of a harbor porpoise stranded along the northern North Carolina coast and from a preenrichment blood culture from a second harbor porpoise. The second porpoise was captured out of habitat (in a low-salinity canal along the northern North Carolina coast) and relocated back into the ocean. Subsequently, DNA was amplified by conventional polymerase chain reaction for DNA sequencing. The 16S–23S intergenic transcribed spacer region obtained from each porpoise was 99.8% similar to that of B. henselae strain San Antonio 2 (SA2), whereas both heme-binding phage-associated pap31 gene sequences were 100% homologous to that of B. henselae SA2. Currently, the geographic distribution, mode of transmission, reservoir potential, and pathogenicity of bloodborne Bartonella species in porpoises have not been determined.

Bartonellosis is a newly emerging worldwide zoonotic disease (1,2) that can be caused by a spectrum of Bartonella species. These members of the alpha subdivision of the class Proteobacteria are gram-negative aerobic bacilli and comprise at least 20 species and subspecies. Infection with Bartonella species causes lymphadenopathy (3), disorders of the central nervous system (including encephalopathy, hemiplegia, epilepsy, and subcortical frontoparietal lesions) (4–7), bacillary angiomatosis and bacillary peliosis (8), fever, adenitis, endocarditis (9–12), hepatosplenic involvement, cutaneous vasculitis, and osteomyelitis in domestic animals and humans (13–15).

Bartonella species have been isolated from numerous domestic and wild terrestrial animals, including cats, dogs, deer, cattle, lions, rabbits, and rodents (16–20). Because Bartonella spp. frequently induce persistent intravascular infections, particularly in reservoir hosts, attributing disease causation to Bartonella infection in animals or in human patients has been difficult, and satisfying Koch postulates for disease causation remains challenging (21).

Because conventional microbiologic techniques lack sensitivity, bartonellosis is usually diagnosed by using polymerase chain reaction amplification of organism-specific DNA sequences or serologic testing (1,22–25). Recently, a more sensitive isolation approach was developed by using Bartonella alpha proteobacteria growth medium (BAPGM) followed by real-time polymerase chain reaction (PCR). This method has greatly facilitated the molecular detection or isolation of Bartonella species from the blood of sick and healthy animals (24). The relative sensitivity of diagnostic methods used to detect Bartonella species infection greatly influences the ability to establish disease causation. The use of these optimized microbiologic techniques facilitated the recognition of bloodborne Bartonella spp. infections in porpoises, as reported in this study.

We report real-time PCR detection of B. henselae SA2 DNA in porpoise blood samples. Harbor porpoises are cetaceans in the family Phocoenidae that are found alone or in small groups in coastal waters, bays, and estuaries in cold, temperate, and subarctic waters of the Northern Hemisphere (26). In the western Atlantic, they range from Baffin Island and Labrador in the north, extending as far south as North Carolina in the winter. Initially, blood samples were screened by using real-time PCR targeting the Bartonella 16S–23S RNA intergenic spacer (ITS) region, or the heme-binding phage-associated gene pap31 (27). Preenrichment liquid BAPGM blood cultures were also screened by real-time PCR, after which conventional PCR was used to obtain DNA for sequencing and identifying Bartonella species to the strain level.

Materials and Methods

Sample Testing

Blood samples (anticoagulated with EDTA) were obtained from a live, stranded yearling female harbor porpoise (Phocoena phocoena) that required humane killing in northern North Carolina in May 2005 (MLC 001) and from a yearling male harbor porpoise. The male porpoise was captured out of habitat (in a low-salinity canal [3 parts salt per 1,000; by comparison, sea water contains 36 parts per 1,000] along the northern North Carolina coast) and relocated to the ocean in March 2005 (AAH 009). The samples were analyzed as follows. Following DNA extraction, real-time PCR (using DNA probes) and conventional PCR were used to screen for Bartonella DNA in each blood sample (23). A preenrichment culture was established from the original sample by using liquid BAPGM (24). After a 7-day incubation period, a sample was removed from the culture flask for conventional PCR and real-time PCR. In addition, sheep blood (used as blood supplement for preenrichment culture) and a sheep blood preenrichment BAPGM culture were screened for Bartonella DNA as a negative control at the time each porpoise sample was processed. Bartonella DNA was not detected in any control samples.

Growth Medium

Preenrichment culture of EDTA-anticoagulated blood samples from the 2 porpoises tested in this study was performed as follows. A 1-mL aliquot of blood was added to 10 mL of BAPGM and incubated at 35°C in a 5% CO2, water-saturated atmosphere as previously described (24).

DNA Extraction and PCR Screening of Blood and Blood Cultures

Screening for Bartonella species DNA was conducted by using conventional PCR and real-time PCR directly with EDTA-anticoagulated blood and from the 7-day postenrichment BAPGM blood culture samples. Gene sequencing was used to establish the species and strain classification. DNA was prepared by using the DNA Mini Kit (Qiagen, Valencia, CA, USA) from 200 μL of the blood sample and from 200 μL of preenrichment blood culture in BAPGM medium. After extraction, DNA concentration and quality were measured by using an absorbance ratio at 260:280 nm.

Real-Time PCR Analysis

Real-time PCR screening for Bartonella species was performed as described previously (23). Scorpion 321 fluorescent probe 5´-FAM-CCG CGT TTT TCA AAG CCC ACG CGG-QUE-HEG-AGA TGA TGA TCC CAA GCC TTC TGG-3´ and oligonucleotide 425as 5´-GGA TRA AYY RGW AAA CCT TYM YCG G-3´ were used as sense and antisense primers, respectively, for screening of the Bartonella genus-specific ITS region. Identification of Bartonella species was conducted by using real-time multiplex PCR with species-specific fluorescent probes (Taqman, Appled Biosystems, Foster City, CA, USA) in conjunction with oligonucleotides 321s 5´-AGA TGA TGA TCC CAA GCC TTC TGG CG-3´ and 421as 5´-GGA TRA AYY RGW AAA CCT TYM YCG G-3´ as forward and reverse primers (Integrated DNA Technologies, Coralville, IA, USA), respectively. The species-specific fluorescent probe sequences (Taqman) used were 5´-FAM-CCA CCG TGG GCT TTG AAA AAC GCT-3´ DBHQ1 for B. henselae, 5´-TexRed-GGG ACT TTA AGG AAG ACA CTT TTG TG-BHQ2-3´ for B. quintana, 5´-ROX-TGC ACA AGC CTC TGA GAG GGA TGA ANG A-BHQ2-3´ for B. clarridgeiae, and Cy3 5´-CTT TCY TGT AAG AGT GTA TTT TTT ATC TAA GA-BHQ2-3´ for B. vinsonii subspecies berkhoffii. Real-time reactions were performed by using a SmartCycler II System (Cepheid, Sunnyvale, CA, USA) in 25-μL reaction volumes as described previously (23). Negative controls were prepared by using DNA extracted from sheep blood samples (the same used as blood supplement in BAPG liquid medium). PCR positive controls contained DNA from sheep blood samples spiked with B. clarridgeiae (ATCC 700095; American Type Culture Collection, Manassas, VA, USA), Bartonella henselae Houston-1 (ATCC 49882), B. quintana Fuller (ATCC VR-358), or B. vinsonii subsp. berkhoffii (ATCC 51672) DNA to a final concentration of 10 fg/μL. real-time PCR conditions were a single hot-start cycle at 95°C for 30 s, followed by 55 cycles of denaturing at 94°C for 10 s, annealing at 58°C for 6 s (for Bartonella) or at 60°C for 6 sec (for the 4 Bartonella species), and final extension at 72°C for 10 s. Positive amplicons were detected by reading fluorescence at the appropriate wavelength.

Conventional PCR Analysis
ITS Region

PCR screening of the Bartonella 16S–23S ITS region was performed on samples that were positive by real-time PCR, as described (24), when amplicon size allows preliminary species identification. Oligonucleotides 321s 5´-AGA TGA TGA TCC CAA GCC TTC TGG-3´ and 983as 5´-TGT TCT YAC AAC AAT GAT GAT G-3´ were used as forward and reverse primers, respectively. The ITS region was amplified in a 25-μL reaction volume that contained 8.5 μL of molecular grade water (Epicentre, Madison, WI, USA) 0.5 μL 10 mmol/L dNTP mixture, 2.5 μL of 10× PCR buffer, 2.5 μL of 25 mmol/L MgCl2, and 0.7 units of Amplitaq Gold DNA polymerase (Applied Biosystems). The reaction mixture was completed by adding 0.25 μL of 30 μmol/L of each forward and reverse primer (Integrated DNA Technologies) and 10 μL of DNA from each sample tested. PCR negative controls contained 10 μL of DNA extracted from BAPGM (when testing BAPGM cultures) or 10 μL of DNA extracted from sheep blood (when testing blood samples). Conventional PCR conditions were a single hot-start cycle at 95°C for 5 min, followed by 45 cycles of denaturing at 94°C for 45 s, annealing at 54°C for 45 s, and extension at 72°C for 45 s. Amplification was completed by an additional cycle at 72°C for 5 min. Products were analyzed by electrophoresis on 2% agarose gels and detected by staining with ethidium bromide and viewing under UV light. Amplicon products were sequenced to identify species strains.

pap31 Gene Amplification

PCR species screening was performed by using primers designed to amplify a consensus sequence of the phage-associated gene pap31 found in several species of the Bartonella genus (27). Oligonucleotides Pap31 1(s) 5´-GAC TTC TGT TAT CGC TTT GAT TT-3´ and Pap31 688 (as) 5´-CAC CAC CAG CAA MAT AAG GCA T-3´ were used as forward and reverse primers, respectively. Amplification of the pap31 gene was performed in a 25-μL final volume reaction as described above. PCR conditions for pap31 gene amplification were a single hot-start cycle at 95°C for 5 min, followed by 45 cycles of denaturing at 94°C for 45 s, annealing at 58°C for 45 s, and extension at 72°C for 45 s. Amplification was completed by an additional cycle at 72°C for 5 min. Products were analyzed by electrophoresis on 2% agarose gels and detected by staining with ethidium bromide and viewing under UV light. Amplicons were sequenced to identify specific strains.

Cloning and Sequencing of ITS and pap31 Gene Amplicons

Bartonella ITS and pap31 DNA sequencing was performed for 2 positive amplicons for both the ITS and pap31 gene to confirm the Bartonella species and strain. The amplified PCR products were cloned into the Plasmid pGEM-T Easy Vector System (Promega, Madison, WI, USA). Recombinants (white colonies) were selected on the basis of the right size of the insert in the plasmid using a plasmid miniprep procedure (Qiagen). Sequencing of plasmid inserts was done by Davis Sequencing, Inc. (Davis, CA, USA). Sequence analysis and alignment with GenBank sequences were performed by using AlignX software (Vector NTI Suite 6.0, InforMax, Inc., Frederick, MD, USA) to identify bacteria at species and strain level.

Results

Blood and Preenrichment Blood Culture Real-Time PCR

Following direct extraction from blood, Bartonella DNA was amplified from 1 (MLC 001) of the 2 porpoises. Real-time PCR amplification of Bartonella DNA was possible from the harbor porpoise stranded along the North Carolina coast, but not from the porpoise (AAH 009) that was captured and released until after the 7-day BAPGM enrichment period. Using a multiplex real-time PCR assay developed in the Vector-Borne Disease Diagnostic Laboratory at North Carolina State University, we identified B. henselae as the infecting species in both porpoises. Bartonella vinsonii subsp. berkhoffii, B. clarridgeae, and B. quintana DNA was not detected by using real-time PCR species-specific probes, which suggests that these species were not present in the original blood samples or in the preenrichment cultures. Bartonella DNA was not detected by real-time PCR in samples extracted from the sheep blood used as a negative control before and after preenrichment culture.

Cloning and Sequencing

The Bartonella species was confirmed by cloning and sequencing the 16S–23S ITS region and the pap31 gene. The ITS and pap31 DNA sequences from both porpoises were consistent with that of B. henselae strain San Antonio 2 (GenBank accession no. AF369529). The 16S–23S ITS sequence matches were 675/677 bp (99.7%) for MLC 001 and 676/677 bp (99.8%) for AAH 009. The ITS sequence from MLC 001 contained 2 bp insertions (a C and a T), at positions 45 and 675, respectively, when compared with the ITS GenBank sequences for B. henselae SA2. Sequences from AAH 009 contained only a C insertion at position 45. The pap31 gene sequences derived from both porpoises matched 540/540 bp (100%) with B. henselae SA2 (GenBank accession no. AF308168).

Discussion

We report the first detection of a Bartonella species from the blood of a cetacean, the detection of B. henselae from a nonterrestrial animal. This study was initiated by a request to use molecular diagnostic to evaluate blood from a stranded sick porpoise and from a porpoise captured out of its natural habitat.

MLC 001, a yearling female that was stranded in a remote location, may have been stranded for many hours before it could safely be reached and humanely killed. There was no evidence of fisheries interaction. The animal was thin, and necropsy showed no food in its stomach. Few obvious gross lesions and parasites were noted. The degree of postmortem autolysis was more than would be expected in a freshly killed animal. This finding, with signs of cranial epaxial and caudal abdominal muscle hemorrhages and the friable condition of the muscle, suggests that the animal's condition likely deteriorated during stranding. Results of histopathologic examination were unremarkable and lesions known to be consistent with bartonellosis were not found.

AAH 009, found swimming in a low-salinity canal, had 2 lacerations (2.5 and 5 cm long) over the left dorsal trunk cranial to the dorsal fin, 1 of which extended the full thickness through the blubber, but was not bleeding. In addition, ≈8 clusters of pinpoint lesions were observed slightly cranial and dorsal to the lacerations, which may have been due to punctures or viral skin lesions. Assessment of the porpoise's behavior, body condition, and hematologic parameters indicated that it was not debilitated despite its unusual location. It was then tagged and released into the ocean. Molecular evidence of Bartonella infection was obtained by direct PCR on whole blood from MLC 001, and by using a recently improved diagnostic method that combines preenrichment blood culture (24) and real-time PCR in samples from AAH 009. An isolate was not obtained from either porpoise after application of the preenrichment BAPGM blood culture onto a blood agar plate.

Recently, various emerging or reemerging infectious diseases or infections of serious epizootic or zoonotic potential have been described in marine mammals (28–32). These include morbillivirus infection, brucellosis, toxoplasmosis, sarcocystosis, papillomavirus infection, and West Nile virus infection (29,31,33). As was the case for brucellosis, recognized as an emerging disease in a marine mammal in 1994 (34,35), bartonellosis may become an important emerging marine mammal infectious disease.

Current evidence indicates that all known Bartonella species are vector transmitted, with bites or scratches (cat scratch disease) providing an alternative means of transmission for B. henselae (2,20). The B. henselae SA2 sequence deposited in GenBank was amplified from an isolate derived from a human lymph node aspiration sample (9). Although exposed to rose thorns and cats, the patient did not recall an animal bite or scratch, and illness developed after a recent tick bite, which was attributed to Amblyomma americanum, based on the location and time of the year. Since the mode of infection was not established in these porpoises, the potential role of trauma, such as induced by tooth raking, or transmission via biting marine invertebrates should be investigated.

As for many fastidious pathogens, difficulties associated with Bartonella detection and isolation have compromised efforts to define the role of these organisms in disease causation. Enhancement of organism-specific DNA detection and isolation through the use of an optimized isolation medium such as BAPGM can aid in evaluating serodiagnostic assays and may advance understanding the diversity, adaptation, and epidemiology of this genus (24,36). Based on the recent use of BAPGM in the North Carolina State University Vector-Borne Disease Diagnostic Laboratory, we believe that chronic infection with Bartonella species can contribute to subtle clinical abnormalities or vague symptoms in companion and wild animals or in humans.

Angiomatosis, an important pathologic manifestation of Bartonella infection in immunocompromised persons (8,21), has been previously reported in bottlenose dolphins (37). Since angiomatous lesions are unusual pathologic lesions and B. henselae is a recently recognized cause of vasoproliferative lesions in humans (8,15), examination of angiomatous lesions from cetaceans for the presence of B. henselae should be a priority in future studies. In addition, the involvement of Bartonella species in disorders of the central nervous system and neurologic dysfunction in animals and humans (4–7) suggests that this genus should be considered in stranding events. Although Bartonella infection in the vasculature of reservoir hosts is generally not accompanied by pathologic changes, Bartonella spp. may become pathogenic in combination with severe stress, malnutrition, increased exposure to toxins, and concurrent infection with other organisms. PCR amplification directly from an extracted blood sample or from a preenrichment blood culture showed that both porpoises in this study were infected with B. henselae SA2. Since infection with Bartonella spp. has been documented in a marine mammal, the clinical impact, mode of transmission, pathology, and epidemiology are areas for additional inquiry.

Dr Maggi is a research postdoctoral associate in the Intracellular Pathogens Laboratory at North Carolina State University, College of Veterinary Medicine. His research interests include development of novel/improved molecular, diagnostic, and culture methods for detection of Bartonella infections in humans and animals.

Top

Acknowledgments

We thank Gregory A. Lewbart for helpful discussions and review of this manuscript; Robert George, Larry J. Hansen, and Gretchen N. Lovewell for facilitating blood collection and testing; and the Virginia Aquarium and Marine Science Stranding Program and the University of North Carolina Wilmington Marine Mammal Stranding Program for assistance during the study.

This research was supported by the state of North Carolina. Funding for stranding responses and sample collection was provided in part by National Oceanic and Atmospheric Administration Fisheries John H. Prescott Marine Mammal Rescue Assistance Grant Program awards to D. Ann Pabst, William A. McLellan (NA03NMFS4390411), and Craig A. Harms (NA04NMF4390040).

Top

References

  1. Boulouis  HJ, Chang  CC, Henn  JB, Kasten  RW, Chomel  BB. Factors associated with the rapid emergence of zoonotic Bartonella infections. Vet Res. 2005;36:383–410. DOIPubMedGoogle Scholar
  2. Breitschwerdt  EB, Kordick  DL. Bartonella infection in animals: carriership, reservoir, potential, pathogenicity, and zoonotic potential for human infection. Clin Microbiol Rev. 2000;13:428–38. DOIPubMedGoogle Scholar
  3. Fournier  PE, Robson  J, Zeaiter  Z, McDougall  R, Byrne  S, Raoult  D. Improved culture from lymph nodes of patients with cat scratch disease and genotypic characterization of Bartonella henselae isolates in Australia. J Clin Microbiol. 2002;40:3620–4. DOIPubMedGoogle Scholar
  4. Angibaud  G, Balague  JP, Lafontan  JF. Bartonella hensalae encephalopathy. Presse Med. 2005;34:297–8. DOIPubMedGoogle Scholar
  5. Munana  KR, Vitek  SM, Hegarty  BC, Kordick  DL, Breitschwerdt  EB. Infection of fetal feline brain cells in culture with Bartonella henselae. Infect Immun. 2001;69:564–9. DOIPubMedGoogle Scholar
  6. Ogura  K, Hara  Y, Tsukahara  H, Maeda  M, Tsukahara  M, Mayumi  M. MR signal changes in a child with cat scratch disease encephalopathy and status epilepticus. Eur Neurol. 2004;51:109–10. DOIPubMedGoogle Scholar
  7. Puligheddu  M, Giagheddu  A, Genugu  F, Giagheddu  M, Marrosu  F. Epilepsia partialis continua in cat scratch disease. Seizure. 2004;13:191–5. DOIPubMedGoogle Scholar
  8. Koehler  JE, Quinn  FD, Berger  TG, LeBoit  PE, Tappero  JW. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med. 1992;327:1625–31. DOIPubMedGoogle Scholar
  9. Dolan  MJ, Wong  MT, Regnery  RL, Jorgensen  JH, Garcia  M, Peters  J, Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med. 1993;118:331–6.PubMedGoogle Scholar
  10. Breitschwerdt  EB, Atkins  CE, Brown  TT, Kordick  DL, Snyder  PS. Bartonella vinsonii subsp. berkhoffi and related members of the alpha subdivision of the Proteobacteria in dogs with cardiac arrhythmias, endocarditis, or myocarditis. J Clin Microbiol. 1999;37:3618–26.PubMedGoogle Scholar
  11. Houpikian  P, Raoult  D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore). 2005;84:162–73. DOIPubMedGoogle Scholar
  12. Znazen  A, Rolain  JM, Hammami  N, Kammoun  S, Hammami  A, Raoult  D. High prevalence of Bartonella quintana endocarditis in Sfax, Tunisia. Am J Trop Med Hyg. 2005;72:503–7.PubMedGoogle Scholar
  13. Ventura  A, Massei  F, Not  T, Massimetti  M, Bussani  R, Maggiore  G. Systemic Bartonella henselae infection with hepatosplenic involvement. J Pediatr Gastroenterol Nutr. 1999;29:52–6. DOIPubMedGoogle Scholar
  14. Ledina  D, Rincic  J, Ivic  I, Marasovic  D, Ledina  D. A child with Bartonella henselae osteomyelitis of the right humerus. Acta Dermatovenerol Croat. 2004;12:92–5.PubMedGoogle Scholar
  15. Spach  DH, Koehler  JE. Bartonella-associated infections. Infect Dis Clin North Am. 1998;12:137–55. DOIPubMedGoogle Scholar
  16. Chang  CC, Chomel  BB, Kasten  RW, Heller  R, Kocan  KM, Ueno  H, Bartonella spp. isolated from wild and domestic ruminants in North America. Emerg Infect Dis. 2000;6:306–11. DOIPubMedGoogle Scholar
  17. Heller  R, Riegel  P, Hansmann  Y, Delacour  G, Bermond  D, Dehio  C, Bartonella tribocorum sp. nov., a new Bartonella species isolated from the blood of wild rats. Int J Syst Bacteriol. 1998;48:1333–9. DOIPubMedGoogle Scholar
  18. Heller  R, Kubina  M, Mariet  P, Riegel  P, Delacour  G, Dehio  C, Bartonella alsatica sp. nov., a new Bartonella species isolated from the blood of wild rabbits. Int J Syst Bacteriol. 1999;49:283–8. DOIPubMedGoogle Scholar
  19. Kordick  DL, Swaminathan  B, Greene  CE, Wilson  KH, Whitney  AM, O'Connor  S, Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii. Int J Syst Bacteriol. 1996;46:704–9. DOIPubMedGoogle Scholar
  20. Kosoy  MY, Regnery  RL, Tzianabos  T, Marston  EL, Jones  DC, Green  D, Distribution, diversity, and host specificity of Bartonella in rodents from the southeastern United States. Am J Trop Med Hyg. 1997;57:578–88.PubMedGoogle Scholar
  21. Jacomo  V, Kelly  PJ, Raoult  D. Natural history of Bartonella infections (an exception to Koch's postulate). Clin Diagn Lab Immunol. 2002;9:8–18.PubMedGoogle Scholar
  22. Breitschwerdt  EB, Hegarty  BC, Maggi  R, Hawkins  E, Dyer  P. Bartonella species as potential cause of epistaxis in dogs. J Clin Microbiol. 2005;43:2529–33. DOIPubMedGoogle Scholar
  23. Maggi  RG, Breitschwerdt  EB. Potential limitations of the 16S-23S rRNA intergenic region for the molecular detection of Bartonella species. J Clin Microbiol. 2005;43:1171–6. DOIPubMedGoogle Scholar
  24. Maggi  RG, Duncan  AB, Breitschwerdt  EB. Novel chemically defined liquid medium for the growth, as single or composed culture, and the primary isolation of Bartonella species from blood and body fluids. J Clin Microbiol. 2005;43:2651–5. DOIPubMedGoogle Scholar
  25. Robinson  JL, Spady  DW, Prasad  E, McColl  D, Artsob  H. Bartonella seropositivity in children with Henoch-Schonlein purpura. BMC Infect Dis. 2005;5:21. DOIPubMedGoogle Scholar
  26. Leatherwood  S, Reeves  RR. Whales and dolphins. San Francisco: Sierra Club Press; 1983. p. 262–6.
  27. Maggi  RG, Breitschwerdt  EB. Isolation of bacteriophage from Bartonella vinsonii subsp. berkhoffii and characterization of Pap 31 gene sequences from bacterial and phage DNA. J Mol Microbiol Biotechnol. 2005;9:44–51. DOIPubMedGoogle Scholar
  28. Dierauf  LA, Gulland  MD, eds. CRC handbook of marine mammal medicine. 2nd ed. Boca Raton (FL): CRC Press; 2001.
  29. Godfroid  J, Cloeckaert  A, Liautard  JP, Kohler  S, Fretin  D, Walravens  K, From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005;36:313–26. DOIPubMedGoogle Scholar
  30. Dubey  JP, Zarnke  R, Thomas  NJ, Wong  SK, van Bonn  W, Briggs  M, Toxoplasma gondii, Neospora caninum, Sarcocystis neurona, and Sarcocystis canis-like infections in marine mammals. Vet Parasitol. 2003;116:275–96. DOIPubMedGoogle Scholar
  31. Dubey  JP. Toxoplasmosis: a waterborne zoonosis. Vet Parasitol. 2004;126:57–72. DOIPubMedGoogle Scholar
  32. Foster  G, Jahans  KL, Reid  RJ, Ross  HM. Isolation of Brucella species from cetaceans, seals and an otter. Vet Rec. 1996;138:583–6. DOIPubMedGoogle Scholar
  33. Harvell  CD, Kim  K, Burkholder  JM, Colwell  RR, Epstein  PR, Grimes  DJ, Emerging marine diseases: climate links and anthropogenic factors. Science. 1999;285:1505–10. DOIPubMedGoogle Scholar
  34. Ross  HM, Jahans  KL, MacMillan  AP, Reid  RJ, Thompson  PM, Foster  G. Brucella species infection in North Sea seal and cetacean populations. Vet Rec. 1996;138:647–8. DOIPubMedGoogle Scholar
  35. Ewalt  DR, Payeur  JB, Martin  BM, Cummins  DR, Miller  WG. Characteristics of a Brucella species from a bottlenose dolphin (Tursiops truncatus). J Vet Diagn Invest. 1994;6:448–52. DOIPubMedGoogle Scholar
  36. LaScola  B, Raoult  D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993–1998). J Clin Microbiol. 1999;37:1899–905.PubMedGoogle Scholar
  37. Turnbull  BS, Cowan  DF. Angiomatosis, a newly recognized disease in Atlantic bottlenose dolphins (Tursiops truncatus) from the Gulf of Mexico. Vet Pathol. 1999;36:28–34. DOIPubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid1112.050969

Table of Contents – Volume 11, Number 12—December 2005

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Edward B. Breitschwerdt, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough St, Raleigh, NC 27606, USA; fax: 919-513-6336

Send To

10000 character(s) remaining.

Top

Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external